KRC-108

CAS 1146944-35-5 MFCD246944355

化学结构图

1146944-35-5
SMILES: Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccccc2o1

化学属性

Mol. Weight433.33
Appearance Solid powder
SolubilitySoluble in DMSO, not in water

别名和识别编码

Chemical NameKRC-108
FormulaC20H20N6O-2HCl or C20H22Cl2N6O
Synonym KRC108; KRC 108; KRC-108
IUPAC Name3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
InChIKeyNLOGXCAMKYLWJP-UHFFFAOYSA-N
InChIInChI=1S/C20H20N6O/c21-19-16(20-25-17-3-1-2-4-18(17)27-20)9-13(10-23-19)14-11-24-26(12-14)15-5-7-22-8-6-15/h1-4,9-12,15,22H,5-8H2,(H2,21,23)
Canonical SMILESNC1=NC=C(C2=CN(C3CCNCC3)N=C2)C=C1C4=NC5=CC=CC=C5O4
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

产品应用

  • KRC-108 is a multiple kinase inhibitor. KRC-108 is a potent inhibitor of Ron, Flt3 and TrkA as well as c-Met. KRC-108 inhibited oncogenic c-Met M1250T and Y1230D more strongly than wild type c-Met. The anti-proliferative activity of KRC-108 was measured by performing a cytotoxicity assay on a panel of cancer cell lines. The GI(50) values (i.e., 50% inhibition of cell growth) for KRC-108 ranged from 0.01 to 4.22 μM for these cancer cell lines. KRC-108 was also effective for the inhibition of tumor growth in human HT29 colorectal cancer and NCI-H441 lung cancer xenograft models in athymic BALB/c nu/nu mice. This molecule should serve as a useful lead for inhibitors targeting kinases and may lead to new therapeutics for the treatment of cancer. (source: Invest New Drugs. 2012 Apr;30(2):518-23. doi: 10.1007/s10637-010-9584-2. Epub 2010 Nov 16. ).

安全信息

Storage condition Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

系列性分类

  1. Medical Research Areas
  2. Angiogenesis
  3. FLT3

相关产品推荐